首頁 > 市場調查報告書 > 醫療設備

e保健遠距離醫療

市場調查報告書

商品編碼

1643911

全球遠距醫療市場 - 2025-2033

Global Telemedicine Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球遠距醫療市場規模達1,297億美元，預估至2033年將達4,888.9億美元，2025-2033年預測期間複合年成長率為16.8%。

遠距醫療的特點是利用電子資訊和通訊技術在另一個地點提供醫療保健服務。這種新穎的策略使醫療保健提供者無需親自就診即可評估、診斷、治療和教育患者。它的用途廣泛，包括遠端諮詢、慢性病監測以及專家諮詢，這對於農村或服務不足地區的人們特別有幫助，因為傳統醫療設施的使用機會有限。

遠距醫療可以使用多種通訊方法，包括視訊會議、行動應用程式和短信，使患者可以在自己的家中或專門的遠距醫療亭方便地獲得護理。遠距醫療因其克服地理障礙和改善醫療保健服務的能力而在全球範圍內越來越受歡迎。它具有多種好處，包括增加患者便利性、降低旅行成本以及透過持續監測更好地管理慢性病。

市場動態：

驅動程式和限制

遠距醫療服務的需求不斷增加

遠距醫療服務的需求不斷成長預計將成為全球遠距醫療市場成長的重要因素。全球遠距醫療市場有望大幅擴張，這主要是由於慢性病盛行率不斷上升、遠距醫療和遠距醫療的成本效益以及技術進步。遠距醫療為傳統醫療服務系統提供了更具成本效益的替代方案，傳統醫療服務系統可能需要高昂的差旅費、面對面諮詢費用和更長的住院時間。

遠距醫療可以進行遠距諮詢和隨訪，減少患者交通費用或請假的需要，從而節省大量費用。例如，根據美國國家癌症研究所的數據，根據經濟情景，遠距醫療可能會因駕駛時間而導致近120 萬美元的潛在未使用資金，以及因就診時間而導致的467,000 美元的收入損失，預計總共節省1.6 美元研究共有 11,600 名參與者。由於遠距醫療的成本效益和節省，全球許多人正在轉向遠距醫療和遠距會診，這正在推動全球遠距醫療市場的發展。

隱私和安全問題

隱私和安全問題等因素預計將阻礙全球遠距醫療市場。由於遠距醫療主要依賴技術來遠端提供醫療保健服務，因此資料外洩和未經授權存取敏感患者資訊的可能性引起了患者和醫生的擔憂。從傳統的面對面諮詢到虛擬互動的轉變帶來了新的隱私風險，例如敏感健康資訊在傳輸過程中被攔截或在設備上保留時被不當訪問的可能性。許多遠距醫療平台可能不完全符合健康保險流通與責任法案 (HIPAA) 等具有挑戰性的標準，該法案對患者資料隱私施加了嚴格的保護，這一事實進一步加劇了這種擔憂。客戶面臨的這些安全問題阻礙了他們利用遠距醫療服務，並阻礙了遠距醫療市場的發展。

Telemedicine is characterized as the use of electronic information and communication technology to provide healthcare services across another location. This novel strategy allows healthcare providers to assess, diagnose, treat, and educate patients without the need for in-person visits. It spans a broad range of uses, including remote consultations, monitoring of chronic medical conditions, and access to specialists, making it particularly helpful for persons in rural or underserved locations with limited access to traditional medical facilities.

Telemedicine can use a variety of communication methods, including video conferencing, mobile applications, and text messaging, allowing patients to get care from the convenience of their own homes or specialized telehealth kiosks. Telemedicine has grown in popularity across the globe due to its capacity to overcome geographical barriers and improve access to healthcare. It has various benefits, including increased patient convenience, reduced travel costs, and better management of chronic conditions through continuous monitoring.

Market Dynamics: Drivers & Restraints

Increasing demand for telemedicine services

The increasing demand for telemedicine services is expected to be a significant factor in the growth of the global telemedicine market. The global telemedicine market is poised for significant expansion, owing mostly to the rising prevalence of chronic diseases, cost benefits of telehealth and telemedicine, and technological advancements. Telemedicine provides a more cost-effective alternative to traditional healthcare delivery systems, which can require high costs for travel, in-person consultations, and longer hospital stays.

Telehealth allows for remote consultations and follow-ups, reducing the need for patients to spend transportation expenditures or take time off work, resulting in significant savings. For instance, according to the National Cancer Institute, based on economic scenarios, telehealth was associated with almost US$1.2 million in potentially unused funds owing to driving time and US$467,000 in lost revenue due to visit time, for a total estimated savings of US$1.6 million among the study's 11,600 participants. Due to the cost benefits and savings of telemedicine, many people across the globe are shifting towards telemedicine and teleconsultations which is driving the global telemedicine market.

Privacy and security concerns

Factors such as privacy and security concerns are expected to hamper the global telemedicine market. Since telemedicine relies primarily on technology to deliver healthcare services remotely, the possibility of data breaches and unauthorized access to sensitive patient information causes concern among both patients and physicians. The shift from traditional in-person consultations to virtual interactions has created new levels of privacy risk, such as the chance of sensitive health information being intercepted during transmission or improperly accessed while retained on devices. This fear is further fueled by the fact that many telehealth platforms may not completely comply with challenging standards like the Health Insurance Portability and Accountability Act (HIPAA), which imposes strict safeguards for patient data privacy. These safety and security concerns faced by the customers hamper them from utilizing telemedicine services and hamper the telemedicine market.

Segment Analysis

The global telemedicine market is segmented based on product type, technology, specialty area, end-user, and region.

Mhealth segment is expected to dominate the global telemedicine market share

The Mhealth segment is anticipated to dominate the global telemedicine market owing to the increasing penetration of smartphones and mobile internet connectivity, technological advancements, and the launch of advanced applications that provide telemedicine services. mHealth, or mobile health, refers to a wide range of mobile technology and applications that improve healthcare services such as remote monitoring, diagnostics, and patient management. The easy use and accessibility provided by mobile applications allow patients to take charge of their health, resulting in better health outcomes. Furthermore, technological improvements have improved the functioning of mHealth devices, making them easier to use and more beneficial for both patients and healthcare practitioners.

In recent times, several important mobile health applications have been launched, strengthening telemedicine capabilities. These applications are intended to enable remote consultations, monitoring, and management of health issues. For instance, in January 2025, AXA - Global Healthcare launched a mobile application designed to support both physical and mental wellbeing through an accessible 'all-in-one' experience, combining health insurance services like access to key policy documents and claims management with virtual care services and bespoke wellbeing features. Therefore, the mHealth segment's anticipated dominance in the global telemedicine market is being strengthened by an increasing number of innovative mobile health applications that improve patient care through increased accessibility and efficiency.

Geographical Analysis

North America is expected to hold a significant position in the global telemedicine market share

North America is expected to hold a significant portion of the global telemedicine market. North America will likely account for a significant share of the global telemedicine market, owing to the rising prevalence of chronic diseases, cost benefits of telehealth and telemedicine, technological advancements, and the launch of applications that offer telemedicine. Technological advances have a significant impact on the telemedicine market in North America. Advanced technologies like artificial intelligence (AI), machine learning (ML), and wearable devices have been integrated into telehealth platforms to improve the effectiveness and usability of remote consultations. These innovations improve not only patient outcomes but also the entire efficiency of healthcare delivery systems.

The recent introduction of telemedicine platforms and apps has considerably contributed to North America's market's dominance. For instance, in December 2024, DocGo Inc., expanded its partnership with SHL Telemedicine to include the SmartHeart portable 12-lead ECG device in DocGo mobile health care units. Thus, offering advanced cardiovascular diagnostics to patients' homes and underserved neighbourhoods in additional markets across the country. As digital health solutions become more incorporated into everyday healthcare procedures, North America is ideally positioned to take the lead in revolutionizing the way medical services are provided and accessed by telemedicine services.

Asia Pacific is growing at the fastest pace in the global telemedicine market

The Asia Pacific region is emerging as the fastest-growing market for telemedicine, owing to a combination of demographic trends, increased healthcare investment, recent launches, and an increasing prevalence of chronic diseases. One of the primary drivers of growth in the Asia-Pacific telemedicine market is a huge increase in healthcare investment from both the public and private sectors. Governments and various private organizations in the region are implementing favourable policies and allocating huge funds to promote telemedicine services.

For instance, in June 2024, C3 Med-Tech, an Ahmedabad-based health tech business, received INR 2 crore in finance from Industrial Metal Powders. Thus, launching innovative telemedicine and AI-powered portable eye screening devices. The combination of telemedicine and AI technologies enabled rapid and accurate diagnosis and intervention, considerably increasing the likelihood of preventing visual impairment and blindness. Due to the increasing investments and allocation of funds, advanced versions of telemedicine services are being launched and developed. Thus, people are opting for the advanced telemedicine services that are developed as they make health and disease management easier and also reduce treatment and hospital costs. Thus, increased investments increase the launch of advanced telemedicine services and drive the Asia Pacific telemedicine market.

Competitive Landscape

The major global players in the global telemedicine market include American Well, ConsultADoctor, Teladoc Health, Inc., MeMD, iCliniq, CareClix, Inc., Mdlive, MDAligne, StatDoctors, and Doctor on Demand among others.

Emerging Players

Galileo, Inc., TalkSpace, and HealthJoy among others

Key Developments

In June 2024, SATYA MicroCapital Limited, in partnership with M-Swasth, launched a free Telemedicine and E-Clinic service. Thus enhancing medical support for over 70 lac persons, including SATYA clients, staff, and their families. The e-Clinic is primarily intended to provide affordable healthcare consultation services to persons in rural locations and run by a Community Health Facilitator (CHF).
In November 2024, TCC, an emerging telemedicine and artificial intelligence service based in Germany, raised €20 million in Series A funding. Thus, expanding its digital capabilities and optimizing hospital procedures, thereby alleviating healthcare system emphasis and maintaining high-quality care standards.
In May 2024, Australian telehealth firm Updoc raised $13 million in funding from Bailador Technology Investments, marking a key milestone for the company. This investment intended to accelerate Updoc's product development and facilitated its international expansion in the field of telemedicine.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviour and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global telemedicine market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Technology
3.3. Snippet by Speciality Area
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Increasing Demand for Telemedicine Market
- 4.1.3. Restraints
- 4.1.4. Privacy and Security Concerns
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Mhealth*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Tele Hospitals/Clinics
6.4. Telehome

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Hardware*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Software
7.4. Telecommunications

8. By Speciality Area

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Speciality Area
- 8.1.2. Market Attractiveness Index, By Speciality Area
8.2. Dermatology*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cardiology
8.4. Gynecology
8.5. Psychiatry
8.6. Trauma Care
8.7. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals & Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Patients
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Speciality Area
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Speciality Area
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Speciality Area
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Speciality Area
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Speciality Area
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. American Well*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. ConsultADoctor
12.3. Teladoc Health, Inc.
12.4. MeMD
12.5. iCliniq
12.6. CareClix, Inc.
12.7. Mdlive
12.8. MDAligne
12.9. StatDoctors
12.10. Doctor on Demand

LIST NOT EXHAUSTIVE